Nationwide carrier screening for congenital adrenal hyperplasia: integrated approach of CYP21A2 pathogenic variant genotyping and comprehensive large gene deletion analysis
Abstract Background Congenital Adrenal Hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD CAH) is an autosomal recessive disorder resulting from pathogenic variants in the CYP21A2 gene. The disorder exhibits variable clinical severity, with the classical form manifesting as salt-wasting cris...
Saved in:
Main Authors: | Yossawat Suwanlikit, Bhakbhoom Panthan, Pawares Chitayanan, Sommon Klumsathian, Angkana Charoenyingwattana, Wasun Chantratita, Objoon Trachoo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Medical Genomics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12920-025-02089-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current and future perspectives on clinical management of classic 21-hydroxylase deficiency
by: Analia Yogi, et al.
Published: (2023-10-01) -
The mutational landscape of ARMC5 in Primary Bilateral Macronodular Adrenal Hyperplasia: an update
by: Lucas Bouys, et al.
Published: (2025-02-01) -
Development of a Hydrocortisone Orodispersible Thin Film Containing Its Succinate Prodrug
by: Clément Boisseillier, et al.
Published: (2025-01-01) -
Semaglutide and laparoscopic sleeve gastrectomy in an adolescent with congenital adrenal hyperplasia due to 21-hydroxylase: a case report
by: Alaina P. Vidmar, et al.
Published: (2025-01-01) -
High clinical utility of long-read sequencing for precise diagnosis of congenital adrenal hyperplasia in 322 probands
by: Yunpeng Wang, et al.
Published: (2025-01-01)